In vitro diagnostic medical devices are essential to the health and safety of Union citizens, and SARS-CoV-2 tests, in particular, are vital in the fight against the pandemic. Therefore, it is necessary to ensure that there is an uninterrupted market supply of such devices in the Union.
Recital 3, Regulation (EU) 2022/112
In forcesince 25 Jan 2022